The Latest Breaking News from MongoDB Inc

As Microsoft’s Azure continues to dominate the cloud computing landscape, here are two tech stocks that are well-positioned to ride Azure’s momentum.

MongoDB (MDB) hit resistance at the declining 21-day moving average and closed down over 2.5% yesterday.

MongoDB Inc (NASDAQ: MDB) shares are trading higher Friday following bullish analyst coverage from UBS. UBS analyst Karl Keirstead upgraded MongoDB from a Neutral rating to a Buy rating and raised the price target from $345 to $450.

UBS analyst Karl Keirstead upgraded MongoDB Inc (NASDAQ:MDB) to Buy from Neutral with a price target of $450, up from $345 (20.8% upside). Channel checks suggested MongoDB benefits directly from the mega-trend to build new applications using a micro-services architecture, solidifying his view that MongoDB is a "play on the apps modernization mega-trend." The shares…

MongoDB Inc (NASDAQ:MDB) has expanded a multi-year strategic collaboration agreement (SCA) with Amazon.Com Inc (NASDAQ:AMZN) Amazon Web Services Inc (AWS). Under the six-year agreement, MongoDB and AWS will deploy initiatives to make it easier for joint customers to advance cloud adoption. Both companies have agreed to collaborate across sales, customer support, solution architecture, marketing. The parties will…

MongoDB Inc (NASDAQ: MDB) has trimmed about one-third of its market cap year-to-date, but shares are showing signs of life after the company reported better-than-expected results earlier this week. 

Analysts remained positive on MongoDB Inc (NASDAQ:MDB) despite slashing their price targets on the stock post Q4 results. Barclays analyst Raimo Lenschow lowered the PT to $410 from $556 (25% upside) and kept an Overweight. Atlas growth accelerated again compared to previous years. Morgan Stanley kept an Overweight with an unchanged price target of $633 (90%…

MongoDB Inc (NASDAQ: MDB) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY23 EPS and sales guidance above analyst estimates.